Transapical Beating-Heart Septal Myectomy for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Initial Clinical Experience
Circulation · 17.11.2026 · 154 (20) · 2011-2026
DOI: 10.1161/circulationaha.126.082486 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 17.11.2026. Verfasst von Jing Fang und 18 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Cardiovascular Surgery (J.F., Y.C., R.L., C.G., J.D., H.W., Q.W., L.C., C.W., T.C., Y.M., S.W., X.W.), Tongji Hospital, Tongji Medical…. Hauptthemen laut MEDLINE: Septal Myectomy, Cardiomyopathy, Hypertrophic, Heart Septum. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Nonobstructive hypertrophic cardiomyopathy (nHCM), defined as hypertrophic cardiomyopathy without left ventricular outflow tract obstruction, remains challenging to treat because of its heterogeneous pathophysiology. This study evaluated the safety and efficacy of transapical beating-heart septal myectomy in patients with symptomatic nHCM. METHODS: Patients with symptomatic, drug-refractory nHCM were prospectively enrolled to undergo transapical beating-heart septal myectomy through a left minithoracotomy. Under real-time transesophageal echocardiographic guidance, septal myectomy was tailored to relieve systolic cavity obliteration and mid-to-apical ventricular obstruction and to enlarge the left ventricular cavity. The primary end point was procedural success at 6 to 12 months postoperatively, defined as fulfillment of all prespecified criteria compared with baseline: ≥1-class improvement in New York Heart Association functional class, ≥10-point increase in Kansas City Cardiomyopathy Questionnaire score, ≥10-mL increase in stroke volume, and normal or grade I diastolic function. RESULTS: Between January 2023 and January 2025, 97 consecutive eligible patients with nHCM underwent transapical beating-heart septal myectomy at Tongji Hospital. At postoperative 6 to 12 months, procedural success was achieved in 87.6%. Specifically, New York Heart Association functional class I increased from 0% at baseline to 93.8% at follow-up, the median Kansas City Cardiomyopathy Questionnaire score improved from 64 (interquartile range, 56–69) to 87 (interquartile range, 82–92; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departments of Cardiovascular Surgery (J.F., Y.C., R.L., C.G., J.D., H.W., Q.W., L.C., C.W., T.C., Y.M., S.W., X.W.), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Hubei Engineering Research Center for Diagnostic and Therapeutic Equipment in Precision Cardiovascular Surgery, Wuhan, China (J.F., Y.C., R.L., Q.W., L.C., C.W., T.C., Y.M., S.W., X.W.).
- Key Laboratory of Organ Transplantation, Ministry of Education; NHC Key Laboratory of Organ Transplantation; Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences; Organ Transplantation Clinical M…
- Medical Ultrasound (W.Z., Y.Z., Y.L.), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Nuclear Medicine (J.Z., X.Z.), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN (H.V.S.).
ORCID-Profile: Yue Chen, Hui Wang, Chen Wang, Taiqiang Chen, Yilei Ma, Ying Zhu, Xiaohua Zhu, Hartzell V Schaff, Song Wan, Xiang Wei
Zitieren
APA
Fang, J., Chen, Y., Zhou, W., Li, R., Gong, C., Du, J., Wang, H., Wang, Q., Cheng, L., Wang, C., Chen, T., Ma, Y., Zhu, Y., Zhou, J., Zhu, X., Schaff, H. V., Liu, Y., Wan, S., & Wei, X. (2026). Transapical Beating-Heart Septal Myectomy for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Initial Clinical Experience. Circulation, 154(20), 2011-2026. https://doi.org/10.1161/circulationaha.126.082486
Vancouver
Fang J, Chen Y, Zhou W, Li R, Gong C, Du J, et al. Transapical Beating-Heart Septal Myectomy for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Initial Clinical Experience. Circulation. 2026;154(20):2011-2026. doi:10.1161/circulationaha.126.082486
BibTeX
@article{Fang2026,
author = {Fang, Jing and Chen, Yue and Zhou, Wei and Li, Rui and Gong, Chaoyu and Du, Jitai and Wang, Hui and Wang, Qunhui and Cheng, Lin and Wang, Chen and Chen, Taiqiang and Ma, Yilei and Zhu, Ying and Zhou, Jianyuan and Zhu, Xiaohua and Schaff, Hartzell V and Liu, Yani and Wan, Song and Wei, Xiang},
title = {Transapical Beating-Heart Septal Myectomy for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Initial Clinical Experience},
journal = {Circulation},
year = {2026},
volume = {154},
number = {20},
pages = {2011--2026},
doi = {10.1161/circulationaha.126.082486}
}
EUVIMED